10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid
|
|
|
- CAS-Nr.
- 3564-73-6
- Bezeichnung:
- 10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid
- Englisch Name:
- 10,11-DIHYDROCARBAMAZEPINE
- Synonyma:
- 10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide;Carbamazepine Impurity 1;CarbaMazepine Related CoMpound A;GP 26-301;Dihydrocarbamazepine;Oxcarbazepine Impurity 4;Oxcarbazepine Impurity RD;10,11-DIHYDROCARBAMAZEPINE;Carbamazepin-10,11-dihydro;CarbaMazepine EP IMpurity-A
- CBNumber:
- CB7188846
- Summenformel:
- C15H14N2O
- Molgewicht:
- 238.28
- MOL-Datei:
- 3564-73-6.mol
|
10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid Eigenschaften
- Schmelzpunkt:
- 205-210 °C(lit.)
- Siedepunkt:
- 394.5±52.0 °C(Predicted)
- Dichte
- 1.232±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- Löslichkeit
- dichloromethane: soluble2.5%, clear, colorless
- Aggregatzustand
- Solid
- pka
- 14.07±0.20(Predicted)
- Farbe
- White to Off-White
- Wasserlöslichkeit
- Soluble in dichloromethane. Insoluble in water.
- BRN
- 196969
- Major Application
- forensics and toxicology
pharmaceutical (small molecule)
- InChI
- 1S/C15H14N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-8H,9-10H2,(H2,16,18)
- InChIKey
- PHNLCHMJDSSPDQ-UHFFFAOYSA-N
- SMILES
- NC(=O)N1c2ccccc2CCc3ccccc13
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Kennzeichnung gefährlicher |
Xn |
|
|
| R-Sätze: |
22-42/43 |
|
|
| S-Sätze: |
22-24/25-45-36/37 |
|
|
| WGK Germany |
3 |
|
|
| RTECS-Nr. |
HN8300000 |
|
|
| HS Code |
29339900 |
|
|
| Speicherklasse |
6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects |
|
|
| Hazard Classifications |
Acute Tox. 4 Oral
Repr. 1A
Skin Sens. 1A
STOT SE 3 |
|
|
| Bildanzeige (GHS) |
 
|
| Alarmwort |
Achtung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
|
P264, P270, P301+P312, P330, P501 |
| H317 |
Kann allergische Hautreaktionen verursachen. |
Sensibilisierung der Haut |
Kategorie 1A |
Warnung |
|
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
| H336 |
Kann Schläfrigkeit und Benommenheit verursachen. |
Spezifische Zielorgan-Toxizität (einmalige Exposition) |
Kategorie 3 (Schläfrigkeit und Benommenheit) |
Warnung |
|
P261, P271, P304+P340, P312,P403+P233, P405, P501 |
|
| Sicherheit |
| P201 |
Vor Gebrauch besondere Anweisungen einholen. |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P302+P352 |
BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen. |
| P308+P313 |
BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen. |
|
10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid Chemische Eigenschaften,Einsatz,Produktion Methoden
S-Sätze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
Chemische Eigenschaften
white crystals or needles
Verwenden
10,11-Dihydrocarbamazepine is used as internal standard during simultaneous determination of carbamazepine and its active metabolite in plasma by liquid chromatography. It can be used in chemiluminescence method for determination of carbamazepine.
Allgemeine Beschreibung
10,11-Dihydrocarbamazepine is an impurity present in dibenzazepine drug used in the treatment of epilepsy. Single-crystal structure of new dimer-based polymorph of 10,11-dihydrocarbamazepine has been investigated.
10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 160)Lieferanten
3564-73-6(10,11-Dihydro-5H-dibenz[b,f]azepin-5-carboxamid)Verwandte Suche:
- f)azepine-5-carboxamide,10,11-dihydro-5h-dibenz(
- 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE
- 10,11-DIHYDROCARBAMAZEPINE
- 10,11-Dihydro5H-dibenzo[b,f]azepine-5-carboxamide
- 10,11-Dihydrocarbamazepine,99%
- 5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide
- 10,11-Dihydrocarbamazepine,10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide
- Carbamazepine Related Compound A (50 mg) (10,11-dihydrocarbamazepine)
- 5H-Dibenz[b,f]azepine-5-carboxaMide, 10,11-dihydro-
- Carbamazepine Impurity 1(Carbamazepine EP Impurity A）
- Oxcarbazepine Impurity RD
- CarbaMazepine EP IMpurity-A
- GP 26-301
- 10,11-DihydrocarbaMazepine 99%
- GP 26-301/ 10,11-Dihydrocarbamazepine/ 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
- Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarbamazepine)
- Oxcarbazepine Impurity 4
- 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HCl
- Carbamazepine Impurity 1
- 10,11-Dihydro-5H-dibenzo[b,f]-azepi
- Carbamazepine EP Impurity A (10,11-Dihydro Carbamazepine)
- Carbamazepine impurity A CRS
- Dihydrocarbamazepine
- Carbamazepine EP Impurity A/ Carbamazepine Related Compound A
- Carbamazepine Related Compound A (10,11-dihydrocarbamazepine) (1093012)
- Carbamazepine USP Related Compound A
- 10,11-Dihydrocarbamazepine
- Carbamazepin-10.11-dihydro in Acetonitrile
- 10,11-Dihydro-5H-dibenzo[b,f]-azepine-5-carboxamide (10,11-Dihydro-carbamazepine)
- 10,11-Dihydrocarbamazepine - [D94775]
- Carbamazepin-10,11-dihydro 100 μg/mL in Acetonitrile
- Carbamazepin-10,11-dihydro
- 10,11-Dihydrocarbamazepine (Carbamazepine Impurity)
- 10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
- CarbaMazepine Related CoMpound A
- 10,11-Dihydrocarbamazepine (98%)
- 3564-73-6
- 5464-73-6
- Building Blocks
- Others
- Heterocyclic Building Blocks
- N-Containing
- Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
- Amines
- Heterocycles
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals
